BoneOncologyTX.com

In this Clinically Challenging Case, Dr. Allan Lipton discusses management of new-onset bone metastasis in a patient with breast cancer. Treatment options and relevant safety issues are presented, and data on the prognostic value of bone turnover markers are also reviewed.

Estimated time to complete activity: 45 minutes
Release date: September 2011
Expiration date: September 30, 2012

Dr. Adam Brufsky presents the case of a breast cancer patient who experiences cancer therapy–induced bone loss while on an aromatase inhibitor. This Clinically Challenging Case also features a discussion of appropriate monitoring for bone loss and fracture risk and an examination of various treatment options.

Estimated time to complete activity: 45 minutes
Release date: September 2011
Expiration date: September 30, 2012

The Bone and Cancer Foundation has developed a new educational presentation, Clinical Perspectives on the Treatment of Bone Metastasis. Among the topics covered in this presentation are: the pathophysiology of bone metastasis; breast cancer and bone metastasis; emerging therapies for skeletal complications in men with prostate cancer; myeloma bone disease; and management of cancer therapy induced bone disease.

Free educational resource for clinicians available on BoneAndCancerFoundation.org

This CE-certified Web activity is based on information presented at a satellite symposium held on December 7, 2010 in Anaheim, California at the 45th American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition and features discussions on the current and emerging therapies used to manage patients with osteoporotic and cancer–related bone loss.

Activity available through USPharmacist.com

Estimated time to complete: 2 hours
Release date: February 2011
Expiration date: February 28, 2013

This podcast is based on information presented at a satellite symposium held on December 7, 2010 in Anaheim, California at the 45th American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition.

Activity available through USPharmacist.com

To download this podcast, right click over the Read More link and choose "Save Target as..."

CME Information

Evaluation

This Current Medical Evidence™ presents information on the clinical impact of bone loss and fracture on men with prostate cancer, provides evidence-based recommendations for the treatment and prevention of bone loss and fracture, and discusses clinical trial data of emerging agents and their potential implications for the future of prostate cancer–related bone disease management.

Release date: November 2010
Expiration date: November 30, 2011
Estimated time to complete activity: 1.5 hours

Order offline print copy

In this patient case-based activity, Dr. Matthew Smith from Harvard Medical School and Massachusetts General Hospital Cancer Center in Boston, Massachusetts, discusses the current and emerging therapies used to improve the management of bone disease in men with prostate cancer. Emerging clinical trial data is also discussed.

Release date: August 31, 2010
Expiration date: August 31, 2011
Estimated time to complete activity: 30 minutes

In this patient case-based activity, Dr. Celestia Higano from the University of Washington in Seattle, Washington, discusses the current and emerging therapies used to improve the management of bone disease in men with prostate cancer. Emerging clinical trial data is also discussed.

Release date: August 31, 2010
Expiration date: August 31, 2011
Estimated time to complete activity: 30 minutes

Prostate cancer is the most common newly diagnosed cancer in men. In the U.S., prostate cancer accounts for 25% of all new cancer diagnoses and 10% of all cancer deaths. This activity discusses the current and emerging therapies used to improve the management of bone disease in men with prostate cancer. Emerging clinical trial data is also discussed.

Estimated time to complete activity: 2 hours
Release date: July 2010
Expiration date: July 31, 2011